My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Reliance Capital gains after board approves independent listing of home finance business

Reliance Capital gains after board approves independent listing of home finance business

Sep 14,2016

The announcement was made yesterday, 13 September 2016, when stock market remained closed on account of Bakri Id.

Meanwhile, the S&P BSE Sensex was down 46.19 points or 0.16% at 28,307.35.

On BSE, so far 6.75 lakh shares were traded in the counter as against average daily volume of 5.01 lakh shares in the past one quarter. The stock hit a high of Rs 561.50 and a low of Rs 546.65 so far during the day. The stock had hit a 52-week high of Rs 574 on 9 September 2016. The stock had hit a 52-week low of Rs 303.60 on 12 February 2016. The stock had outperformed the market over the past one month till 12 September 2016, rising 21.96% compared with 0.71% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 32.06% as against Sensexs 6.45% rise.

The large-cap company has equity capital of Rs 252.63 crore. Face value per share is Rs 10.

Reliance Capital said the independent listing of Reliance Home Finance (RHF) is expected to unlock substantial value for existing shareholders of Reliance Capital. The listing of Reliance Home Finance will also lead to increased management focus and accelerated growth in the home finance business. As per the proposal, 49% stake in Reliance Home Finance Limited will be allotted to all shareholders of Reliance Capital, in the ratio of one share free of cost in Reliance Home Finance for every one share held in Reliance Capital.

Reliance Capital will hold a 51% stake in Reliance Home Finance, and the company will be adequately capitalised to grow the lending book to over Rs 20000 crore in the next 18 months. The proposal is subject to necessary shareholders and other approvals. Reliance Home Finance, a 100% subsidiary of Reliance Capital, provides a wide range of loan solutions like home loan, LAP, construction finance and affordable housing loans. The company reported an AUM of Rs 8259 crore ($1.2 billion) during the quarter ended 30 June 2016.

Mr. Anmol A. Ambani, Director, Reliance Capital said Prime Minister, Narendra Modi has set a goal of affordable housing for all by 2022. There is presently an estimated shortage of 10 crore residential units in India. To address the needs of this sector, Reliance Home Finance has charted an aggressive growth plan in this space, and aims to increase its book size to over Rs 50000 crore in the next few years.

On a consolidated basis, Reliance Capitals net profit rose 3% to Rs 207 crore on 48.3% growth in total income to Rs 3663 crore in Q1 June 2016 over Q1 June 2015.

Reliance Capital, a part of the Reliance Group, is one of Indias leading private sector financial services companies.

Powered by Capital Market - Live News

RCom rings loud after initiating monetization of real estates
Jun 22,2017

The announcement was made after market hours yesterday, 21 June 2017.

Meanwhile, the S&P BSE Sensex was up 203.55 points, or 0.65% to 31,487.19. The S&P BSE Mid-Cap index was down 78.64 points, or 0.53% to 14,929.38.

On the BSE, 21.48 lakh shares were traded in the counter so far, compared with average daily volumes of 38.94 lakh shares in the past one quarter. The stock had hit a high of Rs 20.55 and a low of Rs 19.80 so far during the day. The stock had hit a 52-week high of Rs 55.40 on 31 August 2016. The stock had hit a record low of Rs 17.80 on 14 June 2017.

The stock had underperformed the market over the past one month till 21 June 2017, falling 35.46% compared with 2.69% rise in the Sensex. The scrip had also underperformed the market in past one quarter, slumping 48.23% as against Sensexs 6.1% gains. The scrip had also underperformed the market in past one year, dropping 59.28% as against Sensexs 16.67% gains.

The mid-cap company has equity capital of Rs 1244.49 crore. Face value per share is Rs 5.

Reliance Communications (Rcom) clarified with regards to news titled Rcom puts Mumbai, Delhi real estate assets on the block to pare debt, that the company has initiated the monetization programme for its real estate properties.

The stock has risen 13.01% in seven sessions to its ruling price from a close of Rs 18.05 on 13 June 2017. The stock had seen some bargain hunting recently after the plunge saw the stock hitting record low triggered by ratings agencies Moodys and Fitch on 6 June 2017 further downgrading their ratings on the telecom company and warning about its ability to deal with long-term debt.

However, the company on 7 June 2017 disagreed with the recent rating actions by both these agencies, and believed that these rating actions do not reflect the servicing track record of the company.

The rating agencies have not given due credit to the advanced stage of the corporate transactions (Aircel merger and Tower sale) which are expected to deleverage the companys balance sheet by $4 billion i.e. by 60% within the next few months.

The company added that the recent positive development of the standstill period agreed by lenders has been viewed negatively by the rating agencies on certain technical grounds, while in actual fact the same directly addresses their key concerns about the short term liquidity situation.

RCom had announced on 2 June 2017, that it has been engaged in discussions with its lenders to finalise an overall debt resolution plan, with the objective of expeditiously closing the already announced strategic transactions with Aircel and Brookfield, to immediately reduce debt from Rs 45000 crore to approximately Rs 20000 crore; a reduction of 60% or Rs 25000 crore. The lenders have taken note of the advanced stage of implementation of RComs strategic transformation programme involving the transactions for the Wireless and Towers Business.

The lenders have proposed to give time of seven months till December 2017 to complete the above transactions, and reduce its debt by a substantial amount of Rs 25000 crore, or 60%.

On a consolidated basis, Reliance Communications reported net loss of Rs 948 crore in Q4 March 2017 as against net profit of Rs 79 crore in Q4 March 2016. Net sales declined 24.1% to Rs 4312 crore in Q4 March 2017 over Q4 March 2016.

RCom is an integrated telecommunications service provider.

Powered by Capital Market - Live News

Alembic Pharma in pink of health after USFDA nod for drug
Jun 22,2017

The announcement was made before market hours today, 22 June 2017.

Meanwhile, the S&P BSE Sensex was up 135.80 points, or 0.43% to 31,419.44.

On the BSE, 1,362 shares were traded in the counter so far, compared with average daily volumes of 56,242 shares in the past one quarter. The stock had hit a high of Rs 543 and a low of Rs 538.05 so far during the day.

The stock had hit a 52-week high of Rs 709.30 on 23 March 2017. The stock had hit a 52-week low of Rs 517 on 15 June 2017.

The stock had underperformed the market over the past one month till 21 June 2017, falling 11.4% compared with 2.69% rise in the Sensex. The scrip had also underperformed the market in past one quarter, declining 10.69% as against Sensexs 6.1% gains. The scrip had also underperformed the market in past one year, dropping 1.85% as against Sensexs 16.67% gains.

The large-cap company has equity capital of Rs 37.70 crore. Face value per share is Rs 2.

Alembic Pharmaceuticals has received approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Amantadine Hydrochloride Capsules, USP, 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product Symmetrel Capsules, 100 mg of Endo Pharmaceuticals Inc.

Amantadine Hydrochloride Capsules USP, 100 mg are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. The drug is also indicated in the treatment of parkinsonism and drug induced extrapyramidal reactions.

Amantadine Hydrochloride Capsules have an estimated market size of $37 million in US for twelve months ended December 2016 according to IMS.

Alembic Pharmaceuticals had announced during market hours yesterday, 21 June 2017 that the company received approval from the USFDA for its abbreviated new drug application for Candesartan Cilexetil Tablets, 32 mg. Post that news, the stock had risen 1.7% to Rs 531.90 yesterday, 21 June 2017.

Alembic Pharmaceuticals consolidated net profit rose 2.4% to Rs 93.04 crore on 18.3% rise in net sales to Rs 741.35 crore in Q4 March 2017 over Q4 March 2016.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, manufactures and markets generic pharmaceutical products all over the world.

Powered by Capital Market - Live News

New order boosts Nila Infra
Jun 22,2017

The announcement was made after market hours yesterday, 21 June 2017.

Meanwhile, the S&P SBE Sensex was up 130.82 points or 0.42% at 31,414.46. The S&P BSE Small-Cap index rose 86.46 points or 0.55% at 15,782.73.

On the BSE, 62,000 shares were traded on the counter so far as against the average daily volumes of 5.59 lakh shares in the past one quarter. The stock had hit a high of Rs 17.95 and a low of Rs 17.60 so far during the day. The stock had hit a record high of Rs 19.90 on 6 February 2017 and a 52-week low of Rs 10.25 on 24 June 2016.

The stock had underperformed the market over the past one month till 21 June 2017, advancing 0.57% compared with the Sensexs 2.69% rise. The stock had, however, outperformed the market over the past one quarter, advancing 8% as against the Sensexs 6.1% rise. The scrip had also outperformed the market over the past one year, gaining 50.13% as against the Sensexs 16.67% rise.

The small-cap company has equity capital of Rs 39.34 crore. Face value per share is Rs 1.

Nila Infrastructures received a work order from Ahmedabad Municipal Corporation (AMC) for the Integrated Slum In-Situ Development for public private partnership (PPP) project of about 360 residential units at Ahmedabad under Urban Development & Urban Housing Department, Government of Gujarats Slum Rehabilitation and Redevelopment Policy-2013.

The redevelopment projects total cost outlay is about Rs 25.16 crore with a timeframe of 24 months. As remuneration, the company will get the balance vacant land of about 1,893 sq. mts worth Rs 7.58 crore and the transferable development rights (TDR) of Rs 17.58 crore.

Nila Infrastructures net profit rose 32.9% to Rs 7.71 crore on 7% growth in net sales to Rs 74.09 crore in Q4 March 2017 over Q4 March 2016.

Nila Infrastructures is engaged in developing civil urban infrastructure projects on EPC, turnkey, PPP mode, as well as private white label construction and industrial infrastructure projects.

Powered by Capital Market - Live News

Goa Carbon retracts from record high on profit booking
Jun 22,2017

Meanwhile, the S&P BSE Sensex was up 135.55 points or 0.43% at 31,419.19. The S&P BSE Small-Cap index rose 89.12 points or 0.57% at 15,785.39.

On the BSE, 2.62 lakh shares were traded on the counter so far as against the average daily volumes of 1.36 lakh shares in the past one quarter. The stock had hit a high of Rs 268.20 so far during the day, which is a record high. The stock hit a low of Rs 254.50 so far during the day. The stock had hit a 52-week low of Rs 85.10 on 21 November 2016.

The stock had outperformed the market over the past one month till 21 June 2017, advancing 82.99% compared with the Sensexs 2.69% rise. The stock had also outperformed the market over the past one quarter, gaining 136.98% as against the Sensexs 6.1% rise. The scrip had also outperformed the market over the past one year, spurting 177.03% as against the Sensexs 16.67% rise.

The small-cap company has equity capital of Rs 9.15 crore. Face value per share is Rs 10.

Shares of Goa Carbon had surged 65.98% in the preceding seven trading sessions to settle at Rs 259.85 yesterday, 21 June 2017, from its close of Rs 156.55 on 12 June 2017.

Meanwhile, shares of Goa Carbon turned ex-dividend today, 22 June 2017, for final dividend of Rs 3 per share for the year ended 31 March 2017.

Goa Carbons net profit spurted 1139% to Rs 5.08 crore on 13.9% increase in net sales to Rs 76.32 crore in Q4 March 2017 over Q4 March 2016.

Goa Carbon is engaged in the business of manufacturing and marketing of calcined petroleum coke.

Powered by Capital Market - Live News

Sword & Shield Pharma to hold board meeting
Jun 22,2017

Sword & Shield Pharma will hold a meeting of the Board of Directors of the Company on 6 July 2017.

Powered by Capital Market - Live News

Cadila Healthcare to hold board meeting
Jun 22,2017

Cadila Healthcare will hold a meeting of the Board of Directors of the Company on 26 June 2017.

Powered by Capital Market - Live News

Shriram Transport Finance Company to hold board meeting
Jun 22,2017

Shriram Transport Finance Company will hold a meeting of the Board of Directors of the Company on 29 June 2017.

Powered by Capital Market - Live News

Sree Sakthi Paper Mills to hold board meeting
Jun 22,2017

Sree Sakthi Paper Mills will hold a meeting of the Board of Directors of the Company on 24 June 2017.

Powered by Capital Market - Live News

Nectar Lifescience to hold board meeting
Jun 22,2017

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 27 June 2017.

Powered by Capital Market - Live News

Welterman International to hold board meeting
Jun 22,2017

Welterman International will hold a meeting of the Board of Directors of the Company on 27 June 2017.

Powered by Capital Market - Live News

VKJ Infradevelopers to hold board meeting
Jun 22,2017

VKJ Infradevelopers will hold a meeting of the Board of Directors of the Company on 27 June 2017.

Powered by Capital Market - Live News

Morganite Crucible (India) to hold board meeting
Jun 22,2017

Morganite Crucible (India) will hold a meeting of the Board of Directors of the Company on 26 June 2017.

Powered by Capital Market - Live News

Capital First to hold board meeting
Jun 22,2017

Capital First will hold a meeting of the Board of Directors of the Company on 23 June 2017.

Powered by Capital Market - Live News

Machino Plastics to hold board meeting
Jun 22,2017

Machino Plastics will hold a meeting of the Board of Directors of the Company on 28 July 2017.

Powered by Capital Market - Live News

PAE to hold board meeting
Jun 22,2017

PAE will hold a meeting of the Board of Directors of the Company on 27 June 2017.

Powered by Capital Market - Live News